Bimekizumab Remission and High Disease Control Over 4 Years in Patients With Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials. J of Skin 2026, 10 (2), s758. https://doi.org/10.25251/0bnq3318.